Around only 40 patients recruited in 6 months since trial commenced. Oh dear.
I certainly hope recruitment growth is not linear!
This is a lot slower than I expected.
Management need to address the issue of another capital raise at the conference call as the trial looks likely to continue into next year.
Ann: Clinical Trial Update, page-2
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable